Comparison of the activity of three different HSP70 inhibitors on apoptosis, cell cycle arrest, autophagy inhibition, and HSP90 inhibition

Cancer Biology and Therapy

Volumn 15, Issue 2, 2014, Pages 194-199

  Budina Kolomets, Anna ^a   Balaburski, Gregor M ^a,c   Bondar, Anastasia ^a   Beeharry, Neil ^b   Yen, Tim ^b   Murphy, Maureen E ^a  

^a WISTAR INSTITUTE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c Laboratory of Molecular and Cellular Biology of Hematopoiesis   (United States)

Author keywords

Anaphase promoting complex; Autophagy; Cell cycle; MKT 077; PES; PES Cl; Phenylethynesulfonamide; Ver 155008

Indexed keywords

ANAPHASE PROMOTING COMPLEX; AUTOPHAGY; CELL CYCLE; MKT-077; PES; PES-CL; PHENYLETHYNESULFONAMIDE; VER-155008;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; HSP70 HEAT-SHOCK PROTEINS; HUMANS; PURINE NUCLEOSIDES; PYRIDINES; SULFONAMIDES; THIAZOLES;

EID: 84894517702     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.26720     Document Type: Article

References (24)

1. Leu JI, Pimkina J, Frank A, Murphy ME, George DL. A small molecule inhibitor of inducible heat shock protein 70. Mol Cell 2009; 36: 15-27; PMID: 19818706; http://dx.doi.org/10.1016/j.molcel.2009.09.023
2. Balaburski GM, Leu JI, Beeharry N, Hayik S, Andrake MD, Zhang G, Herlyn M, Villanueva J, Dunbrack RL Jr., Yen T, et al. A modified HSP70 inhibitor shows broad activity as an anticancer agent. Mol Cancer Res 2013; 11: 219-29; PMID: 23303345; http://dx.doi.org/10.1158/1541-7786.MCR-12-0547-T
3. Nylandsted J, Gyrd-Hansen M, Danielewicz A, Fehrenbacher N, Lademann U, Høyer-Hansen M, Weber E, Multhoff G, Rohde M, Jäättelä M. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med 2004; 200: 425-35; PMID: 15314073; http://dx.doi.org/10.1084/jem.20040531 (Pubitemid 39121900)
4. Leu JI, Pimkina J, Pandey P, Murphy ME, George DL. HSP70 inhibition by the small-molecule 2-phenylethynesulfonamide impairs protein clearance pathways in tumor cells. Mol Cancer Res 2011; 9: 936-47; PMID: 21636681; http://dx.doi.org/10.1158/1541-7786.MCR-11-0019
5. Powers MV, Clarke PA, Workman P. Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis. Cancer Cell 2008; 14: 250-62; PMID: 18772114; http://dx.doi.org/10.1016/j.ccr.2008.08.002
6. Miniowitz-Shemtov S, Teichner A, Sitry-Shevah D, Hershko A. ATP is required for the release of the anaphase-promoting complex/cyclosome from inhibition by the mitotic checkpoint. Proc Natl Acad Sci U S A 2010; 107: 5351-6; PMID: 20212161; http://dx.doi.org/10.1073/pnas.1001875107
7. Patury S, Miyata Y, Gestwicki JE. Pharmacological targeting of the Hsp70 chaperone. Curr Top Med Chem 2009; 9: 1337-51; PMID: 19860737; http://dx.doi.org/10.2174/156802609789895674
8. Powers MV, Jones K, Barillari C, Westwood I, van Montfort RL, Workman P. Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone? Cell Cycle 2010; 9: 1542-50; PMID: 20372081; http://dx.doi.org/10.4161/cc.9.8.11204
9. Murphy ME. The HSP70 family and cancer. Carcinogenesis 2013; 34: 1181-8; PMID: 23563090; http://dx.doi.org/10.1093/carcin/bgt111
10. Williamson DS, Borgognoni J, Clay A, Daniels Z, Dokurno P, Drysdale MJ, Foloppe N, Francis GL, Graham CJ, Howes R, et al. Novel adenosine-derived inhibitors of 70 kDa heat shock protein, discovered through structure-based design. J Med Chem 2009; 52: 1510-3; PMID: 19256508; http://dx.doi.org/10.1021/ jm801627a
11. Massey AJ, Williamson DS, Browne H, Murray JB, Dokurno P, Shaw T, Macias AT, Daniels Z, Geoffroy S, Dopson M, et al. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells. Cancer Chemother Pharmacol 2010; 66: 535-45; PMID: 20012863; http://dx.doi.org/10.1007/s00280-009-1194-3
12. Chiba Y, Kubota T, Watanabe M, Matsuzaki SW, Otani Y, Teramoto T, Matsumoto Y, Koya K, Kitajima M. MKT-077, localized lipophilic cation: antitumor activity against human tumor xenografts serially transplanted into nude mice. Anticancer Res 1998; 18(2A): 1047-52; PMID: 9615763 (Pubitemid 28239638)
13. Koren J 3rd, Miyata Y, Kiray J, O'Leary JC 3rd, Nguyen L, Guo J, Blair LJ, Li X, Jinwal UK, Cheng JQ, et al. Rhodacyanine derivative selectively targets cancer cells and overcomes tamoxifen resistance. PLoS One 2012; 7:e35566; PMID: 22563386; http://dx.doi.org/10.1371/journal.pone.0035566
14. Koya K, Li Y, Wang H, Ukai T, Tatsuta N, Kawakami M, Shishido, Chen LB. MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation. Cancer Res 1996; 56: 538-43; PMID: 8564968 (Pubitemid 26048603)
15. Rousaki A, Miyata Y, Jinwal UK, Dickey CA, Gestwicki JE, Zuiderweg ER. Allosteric drugs: the interaction of antitumor compound MKT-077 with human Hsp70 chaperones. J Mol Biol 2011; 411: 614-32; PMID: 21708173; http://dx.doi.org/10. 1016/j.jmb.2011.06.003
16. Budina-Kolomets A, Hontz RD, Pimkina J, Murphy ME. A conserved domain in exon 2 coding for the human and murine ARF tumor suppressor protein is required for autophagy induction. Autophagy 2013; 9: 9; PMID: 23939042; http://dx.doi.org/10.4161/auto.25831
17. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA, Ballabio A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008; 4: 151-75; PMID: 18188003 (Pubitemid 351231180)
18. Sudakin V, Chan GK, Yen TJ. Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J Cell Biol 2001; 154: 925-36; PMID: 11535616; http://dx.doi.org/10.1083/jcb.200102093 (Pubitemid 34286173)
19. Yang Y, Fiskus W, Yong B, Atadja P, Takahashi Y, Pandita TK, Wang HG, Bhalla KN. Acetylated hsp70 and KAP1-mediated Vps34 SUMOylation is required for autophagosome creation in autophagy. Proc Natl Acad Sci U S A 2013; 110: 6841-6; PMID: 23569248; http://dx.doi.org/10.1073/pnas.1217692110
20. Rohde M, Daugaard M, Jensen MH, Helin K, Nylandsted J, Jäättelä M. Members of the heatshock protein 70 family promote cancer cell growth by distinct mechanisms. Genes Dev 2005; 19: 570-82; PMID: 15741319; http://dx.doi.org/10.1101/gad.305405 (Pubitemid 40314989)
21. Hunt CR, Dix DJ, Sharma GG, Pandita RK, Gupta A, Funk M, Pandita TK. Genomic instability and enhanced radiosensitivity in Hsp70.1- and Hsp70.3- deficient mice. Mol Cell Biol 2004; 24: 899-911; PMID: 14701760; http://dx.doi.org/10.1128/MCB.24.2.899-911.2004 (Pubitemid 38057939)
22. Marteil G, Gagné JP, Borsuk E, Richard-Parpaillon L, Poirier GG, Kubiak JZ. Proteomics reveals a switch in CDK1-associated proteins upon M-phase exit during the Xenopus laevis oocyte to embryo transition. Int J Biochem Cell Biol 2012; 44: 53-64; PMID: 21959252; http://dx.doi.org/10.1016/j.biocel.2011. 09.003
23. Honey S, Schneider BL, Schieltz DM, Yates JR, Futcher B. A novel multiple affinity purification tag and its use in identification of proteins associated with a cyclin-CDK complex. Nucleic Acids Res 2001; 29:E24; PMID: 11160944; http://dx.doi.org/10.1093/nar/29.4.e24
24. Zhu D, Dix DJ, Eddy EM. HSP70-2 is required for CDC2 kinase activity in meiosis I of mouse spermatocytes. Development 1997; 124: 3007-14; PMID: 9247342 (Pubitemid 27370915)